Why We Fund Deep Tech for Crohn's and ADHD
Our thesis on deploying capital into specialized health tech where personal experience provides an unfair operational advantage.
Founder as User Zero
Building tools for cognitive focus disorders (ADHD) and chronic inflammatory disease (Crohn's) requires a degree of empathy and lived experience that cannot be replicated in a market research brief. When the founder is user zero, product design cycles compress dramatically because there is no translation layer between lived pain and technical solution.
We invest in this space because we live in it. We know which tools actually help, which are cosmetic, and which are actively harmful. That is an edge most capital allocators simply do not have. They are guessing from the outside. We are building from the inside.
The Productivity Stack for Non-Linear Brains
ADHD is not a deficit. It is a different operating system running on the wrong interface. The tools that exist today were designed by neurotypical people for neurotypical workflows. Task lists, calendar blocks, linear project management: none of it maps to how an ADHD brain actually processes urgency and priority.
We invest in tools that understand this. Systems with friction built in the right places, not the wrong ones. ReadWall is a direct product of this philosophy. You cannot open Instagram until you have read. The friction is intentional. The wall is the product.
Crohn's creates a different set of constraints. Unpredictable energy. Variable capacity. The need for tools and systems that are forgiving of inconsistency but still drive forward progress over time. This shapes how we think about product loops, habit formation, and the difference between tools that demand consistency and tools that reward showing up at all.
Why This is a Real Market
Roughly 10 percent of the global population has ADHD. Crohn's disease affects millions across the world and the diagnosis rate is rising. These are not niche edge cases. These are massive underserved markets where the existing software ecosystem is either absent or built for a different user entirely.
Capital that enters this space with genuine product understanding, rather than surface-level wellness branding, wins disproportionately. We do not need a large slice of the market. We need the right product for the right user who has been waiting for something that actually works.
This is where Astral Vault Collective deploys. Not into trends. Into conviction. The kind that comes from personal experience, not a slide deck.